?
История популяционного здоровья
Демографическое обозрение. 2021. Т. 8. № 2. С. 128-133.
Vlassov V., Injury Prevention 2016 Vol. 22 No. 1 P. 3-18
Abstract
Background The Global Burden of Diseases (GBD), Injuries, and Risk Factors study used the disability-adjusted life year (DALY) to quantify the burden of diseases, injuries, and risk factors. This paper provides an overview of injury estimates from the 2013 update of GBD, with detailed information on incidence, mortality, DALYs and rates of change from 1990 ...
Added: January 2, 2016
Vlassov V., The Lancet 2016 Vol. 388 No. 10053 P. 1725-1774
Background
Established in 2000, Millennium Development Goal 4 (MDG4) catalysed extraordinary political, financial, and social commitments to reduce under-5 mortality by two-thirds between 1990 and 2015. At the country level, the pace of progress in improving child survival has varied markedly, highlighting a crucial need to further examine potential drivers of accelerated or slowed decreases in ...
Added: October 13, 2016
Vlassov V., The Lancet 2018 Vol. 392 No. 10159 P. 2091-2138
Background
Efforts to establish the 2015 baseline and monitor early implementation of the UN Sustainable Development Goals (SDGs) highlight both great potential for and threats to improving health by 2030. To fully deliver on the SDG aim of “leaving no one behind”, it is increasingly important to examine the health-related SDGs beyond national-level estimates. As part ...
Added: November 16, 2018
Vlassov V., The BMJ 2019 Vol. 364 P. 1-11
Objectives To use the estimates from the Global Burden of Disease Study 2016 to describe patterns of suicide mortality globally, regionally, and for 195 countries and territories by age, sex, and Socio-demographic index, and to describe temporal trends between 1990 and 2016.Design Systematic analysis.Main outcome measures Crude and age standardised rates from suicide mortality and ...
Added: July 12, 2019
Vlassov V., The Lancet 2018 Vol. 392 No. 10153 P. 1138-1146
Background
Over the past few decades, social and economic changes have had substantial effects on health and wellbeing in Russia. We aimed to use data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to evaluate trends in mortality, causes of death, years lived with disability (YLDs), years of life lost ...
Added: September 2, 2018
Vlassov V., The Lancet HIV 2016 Vol. 3 No. 8 P. e361-e387
Background
Timely assessment of HIV/AIDS burden is essential for policy-setting and program evaluation. Based on
the Global Burden of Disease study 2015 (GBD 2015), we provide national estimates of levels and trends
of HIV/AIDS incidence, prevalence, ART coverage and mortality for 195 countries and territories from
1980 to 2015.
Methods
For countries without high quality vital registration data, we estimated prevalence ...
Added: July 9, 2016
Vlassov V., The Lancet 2016 Vol. 388 No. 10053 P. 1603-1658
Background
Healthy life expectancy (HALE) and disability-adjusted life-years (DALYs) provide summary measures of health across geographies and time that can inform assessments of epidemiological patterns and health system performance, help to prioritise investments in research and development, and monitor progress toward the Sustainable Development Goals (SDGs). We aimed to provide updated HALE and DALYs for geographies ...
Added: October 13, 2016
Vlassov V., The Lancet 2015 Vol. 386 No. 10010 P. 2287-2323
Background
The Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015) provides an up to date synthesis of the evidence on risk factor exposure and the burden of disease attributable to these risks. By providing national and subnational assessments spanning 25 years, the GBD 2015 can help inform debates on the importance of ...
Added: August 20, 2016
Vlassov V., The Lancet 2016 Vol. 388 No. 10053 P. 1813-1850
Background
In September, 2015, the UN General Assembly established the Sustainable Development Goals (SDGs). The SDGs specify 17 universal goals, 169 targets, and 230 indicators leading up to 2030. We provide an analysis of 33 health-related SDG indicators based on the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015).
Methods
We applied statistical methods ...
Added: September 25, 2016
GBD 2019 Demographics Collaborators .., Vlassov V., The Lancet 2020 Vol. 396 No. 10258 P. 1160-1203
Background
Accurate and up-to-date assessment of demographic metrics is crucial for understanding a wide range of social, economic, and public health issues that affect populations worldwide. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 produced updated and comprehensive demographic assessments of the key indicators of fertility, mortality, migration, and population for 204 ...
Added: October 16, 2020
Vlassov V., The Lancet 2017 Vol. 389 No. 10082 P. 1885-1906
The scale-up of tobacco control, especially after the adoption of the Framework Convention for Tobacco Control, is a major public health success story. Nonetheless, smoking remains a leading risk for early death and disability worldwide, and therefore continues to require sustained political commitment. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) offers ...
Added: April 9, 2017
Vlassov V., JAMA Oncology 2017 Vol. 3 No. 4 P. 524-548
Importance:
Cancer is the second leading cause of death worldwide. Current estimates on the burden of cancer are needed for cancer control planning.
Objective:
To estimate mortality, incidence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 32 cancers in 195 countries and territories from 1990 to 2015.
Evidence Review:
Cancer mortality was estimated ...
Added: December 25, 2016
Vlassov V., Vishnevsky A. G., The Lancet Public Health 2017 Vol. 2 No. 5 P. e207-e208
In studies of massive changes in social life, researchers often have to rely on low-quality retrospective data such as memoirs and manipulated government reports as opposed to reliable data such as vital registration. The dissolution of the Soviet Union in 1991 was an unpredictable event with large-scale consequences for the lives of millions of Russians. ...
Added: April 13, 2017
Vlassov V.V., The Lancet 2016 Vol. 388 No. 10049 P. 1081-1088
Background
With recent improvements in vaccines and treatments against viral hepatitis, an improved understanding of the burden of viral hepatitis is needed to inform global intervention strategies. We used data from the Global Burden of Disease (GBD) Study to estimate morbidity and mortality for acute viral hepatitis, and for cirrhosis and liver cancer caused by viral ...
Added: July 9, 2016
Vlassov V., The Lancet 2016 Vol. 388 No. 10053 P. 1545-1602
Background
Non-fatal outcomes of disease and injury increasingly detract from the ability of the world's population to live in full health, a trend largely attributable to an epidemiological transition in many countries from causes affecting children, to non-communicable diseases (NCDs) more common in adults. For the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 ...
Added: October 13, 2016
Vlassov V., The Lancet 2016 Vol. 388 No. 10053 P. 1459-1544
Background
Improving survival and extending the longevity of life for all populations requires timely, robust evidence on local mortality levels and trends. The Global Burden of Disease 2015 Study (GBD 2015) provides a comprehensive assessment of all-cause and cause-specific mortality for 249 causes in 195 countries and territories from 1980 to 2015. These results informed an ...
Added: October 13, 2016
Vlassov V., JAMA Pediatrics 2017 Vol. 171 No. 6 P. 573-592
Importance Comprehensive and timely monitoring of disease burden in all age groups, including children and adolescents, is essential for improving population health.
Objective To quantify and describe levels and trends of mortality and nonfatal health outcomes among children and adolescents from 1990 to 2015 to provide a framework for policy discussion.
Evidence Review Cause-specific mortality and nonfatal ...
Added: April 6, 2017
Vlassov V., JAMA Pediatrics 2016 Vol. 170 No. 3 P. 267-287
Importance The literature focuses on mortality among children younger than 5 years. Comparable information on nonfatal health outcomes among these children and the fatal and nonfatal burden of diseases and injuries among older children and adolescents is scarce.
Objective To determine levels and trends in the fatal and nonfatal burden of diseases and injuries among younger ...
Added: December 22, 2015
GBD 2019 Adolescent Young Adult Cancer C., Otstavnov S., Vlassov V., The Lancet Oncology 2022 Vol. 23 No. 1 P. 27-52
Background: In estimating the global burden of cancer, adolescents and young adults with cancer are often overlooked, despite being a distinct subgroup with unique epidemiology, clinical care needs, and societal impact. Comprehensive estimates of the global cancer burden in adolescents and young adults (aged 15-39 years) are lacking. To address this gap, we analysed ...
Added: December 13, 2021
Vlassov V., The Lancet 2015 Vol. 386 No. 10009 P. 2145-2191
Background
The global burden of diseases, injuries and risk factors 2013 study (GBD 2013) seeks to synthesize all
available epidemiological data using a coherent measurement framework, standardized estimation
methods, and transparent data sources to facilitate comparisons of health loss across causes, age‐sex
groups, and geographies and over time. The GBD can be used to generate summary measures such ...
Added: August 21, 2015
Vlassov V., The Lancet Neurology 2024 P. 1-10
Background
Disorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, ...
Added: March 16, 2024
Haagsma J., James S., Castle C. et al., Injury Prevention 2020 Vol. 26 No. Supp 1 P. i12-i26
Background The epidemiological transition of non-communicable diseases replacing infectious diseases as the main contributors to disease burden has been well documented in global health literature. Less focus, however, has been given to the relationship between sociodemographic changes and injury. The aim of this study was to examine the association between disability-adjusted life years (DALYs) from ...
Added: February 26, 2020
Vlassov V., The Lancet 2016 Vol. 388 No. 1053 P. 1775-1812
coBverage of specific reproductive health care services as well as assessment of observed versus expected maternal mortality as a function of Socio-Demographic Index (SDI), a summary indicator derived from measures of income per capita, educational attainment, and fertility.
Findings
Only ten countries achieved MDG 5, but 122 of 195 countries have already met SDG 3.1. Geographic disparities ...
Added: July 20, 2016
Feigin V. L., Roth G. A., Naghavi M. et al., The Lancet Neurology 2016 Vol. 15 No. 9 P. 913-924
Background
The contribution of modifiable risk factors to the increasing global and regional burden of stroke is unclear, but knowledge about this contribution is crucial for informing stroke prevention strategies. We used data from the Global Burden of Disease Study 2013 (GBD 2013) to estimate the population-attributable fraction (PAF) of stroke-related disability-adjusted life-years (DALYs) associated with ...
Added: June 10, 2016